Chairman Abu Ahmed has called for urgent policy reforms to attract new companies to the capital market.  If companies were given proper incentives, they would opt to raise funds from the public ...

Explore the transformative role of AI and biotechnology in reshaping sustainable mining practices. These cutting-edge technologies are helping the industry reduce its environmental footprint ...

Genetic evidence of the H5N1 bird flu virus was found in grocery store milk in the United States this week, according to the Food and Drug administration. But what does this mean for consumers? In ...

Or, maybe, it's just a grey wolf with a few tweaks. American biotech company Colossal Biosciences made a surprise announcement Monday, claiming it had brought the dire wolf back from the dead ...

America must invest at least $15 billion over the next five years to support its domestic biotechnology sector if it doesn’t want to lose to China, warns a national security commission made up ...

However, the prospect of future industry-specific tariffs could intensify selling pressure on biotech stocks. Despite the uncertainty, top hedge fund managers have invested millions of dollars in ...

A biotech company says it has bred three animals with key physical features of the dire wolf — a species that has been extinct for more than 12,000 years. Colossal Biosciences says it used novel ...

The U.S.-based biotechnology company is also known for its ambitious goal of bringing back the extinct woolly mammoth by 2028. This dire wolf pup is among the first of its species born in around ...

The comprehensive report from the bipartisan National Security Commission on Emerging Biotechnology (NSCEB) delivers a “sobering, even frightening,” conclusion: that China is quickly ascending to ...

Caitlin O'Kane is a New York City journalist who works on the CBS News social media team as a senior manager of content and production. She writes about a variety of topics and produces "The ...

Legend Biotech has no tariff exposure and manufactures Carvykti entirely in the U.S. for both U.S. and EU markets. HC Wainwright maintains a $75 target, citing Carvykti’s strong efficacy and ...